Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Ballard

Showing results (471-480 of 480) with videos related to

Pageof 48
Sort By:
You have reached the last page of results.This site can display upto 480 results.
Alzheimer'S & Dementia (New York, N. Y.)|May 24, 2024
Genetic associations with psychosis and affective disturbance in Alzheimer's diseaseInga Margret Antonsdottir, Byron Creese, Lambertus Klei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 9, 2013
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureYonas E Geda, Lon S Schneider, Laura N Gitlin, et al.
Health Technology Assessment (Winchester, England)|June 20, 2017
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Molecular Psychiatry|June 11, 2021
Genome-wide association identifies the first risk loci for psychosis in Alzheimer diseaseMary Ann A DeMichele-Sweet, Lambertus Klei, Byron Creese, et al.
Nature Medicine|January 6, 2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathologyHanna Huber, Laia Montoliu-Gaya, Wagner S Brum, et al.
The New England Journal of Medicine|June 20, 2024
Homozygosity for R47H in <i>TREM2</i> and the Risk of Alzheimer's DiseaseHreinn Stefansson, G Bragi Walters, Gardar Sveinbjornsson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Genomic analyses reveal new insights into Alzheimer's diseaseEmil Uffelmann, Douglas P Wightman, Shahram Bahrami, et al.
Pageof 48

Showing results (471-480 of 480) with videos related to

Sort By:
Pageof 48
You have reached the last page of results.This site can display upto 480 results.
Alzheimer'S & Dementia (New York, N. Y.)|May 24, 2024
Genetic associations with psychosis and affective disturbance in Alzheimer's diseaseInga Margret Antonsdottir, Byron Creese, Lambertus Klei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 9, 2013
Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureYonas E Geda, Lon S Schneider, Laura N Gitlin, et al.
Health Technology Assessment (Winchester, England)|June 20, 2017
Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendationsLucy Webster, Derek Groskreutz, Anna Grinbergs-Saull, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Alzheimer'S Research & Therapy|February 18, 2021
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?Grazia Daniela Femminella, Nicholas R Livingston, Sanara Raza, et al.
Nature Medicine|December 1, 2025
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trialPaul Edison, Grazia Daniela Femminella, Craig Ritchie, et al.
Molecular Psychiatry|June 11, 2021
Genome-wide association identifies the first risk loci for psychosis in Alzheimer diseaseMary Ann A DeMichele-Sweet, Lambertus Klei, Byron Creese, et al.
Nature Medicine|January 6, 2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathologyHanna Huber, Laia Montoliu-Gaya, Wagner S Brum, et al.
The New England Journal of Medicine|June 20, 2024
Homozygosity for R47H in <i>TREM2</i> and the Risk of Alzheimer's DiseaseHreinn Stefansson, G Bragi Walters, Gardar Sveinbjornsson, et al.
Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Genomic analyses reveal new insights into Alzheimer's diseaseEmil Uffelmann, Douglas P Wightman, Shahram Bahrami, et al.
Pageof 48